Buzzscore: Consumers Turn on Tylenol
Brandweek’s Todd Wasserman reporting on the sharp decline in Tylenol’s brand buzz following the FDA’s warning that acetaminophen, in particular, has been linked to liver damage: The firm, whose BrandIndex polls 5,000 U.S. adults daily on brand perception, found Tylenol’s negative buzz grew in a very short amount of time. On June 25, the brand’s
Read More...